BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 28606265)

  • 1. [The fundus manifestations and SD-OCT findings of patients with acute Vogt-Koyanagi-Harada disease].
    Li B; Ye JJ; Zhang MF; Li DH
    Zhonghua Yan Ke Za Zhi; 2017 Jun; 53(6):436-439. PubMed ID: 28606265
    [No Abstract]   [Full Text] [Related]  

  • 2. [Autofluorescence combined with spectral domain optical coherence tomography for diagnosis and follow-up of acute Vogt-Koyanagi-Harada disease].
    Tian S; Yao J; Wang J; Zhang J; Zhou A
    Nan Fang Yi Ke Da Xue Xue Bao; 2021 Jan; 41(1):135-140. PubMed ID: 33509766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tomographic features of serous retinal detachment with multilobular dye pooling in acute Vogt-Koyanagi-Harada disease.
    Yamaguchi Y; Otani T; Kishi S
    Am J Ophthalmol; 2007 Aug; 144(2):260-5. PubMed ID: 17533104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the optical coherence tomographic characters between acute Vogt-Koyanagi-Harada disease and acute central serous chorioretinopathy.
    Lin D; Chen W; Zhang G; Huang H; Zhou Z; Cen L; Chen H
    BMC Ophthalmol; 2014 Jun; 14():87. PubMed ID: 24974016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and multimodal imaging characteristics of acute Vogt-Koyanagi-Harada disease unassociated with clinically evident exudative retinal detachment.
    Attia S; Khochtali S; Kahloun R; Ammous D; Jelliti B; Ben Yahia S; Zaouali S; Khairallah M
    Int Ophthalmol; 2016 Feb; 36(1):37-44. PubMed ID: 25939987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute Vogt-Koyanagi-Harada disease in enhanced spectral-domain optical coherence tomography.
    Ishihara K; Hangai M; Kita M; Yoshimura N
    Ophthalmology; 2009 Sep; 116(9):1799-807. PubMed ID: 19643489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the Clinical Manifestations between Acute Vogt-Koyanagi-Harada Disease and Acute Bilateral Central Serous Chorioretinopathy.
    Shin WB; Kim MK; Lee CS; Lee SC; Kim H
    Korean J Ophthalmol; 2015 Dec; 29(6):389-95. PubMed ID: 26635455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optical coherence tomography in the acute and chronic phases of Vogt-Koyanagi-Harada disease.
    Parc C; Guenoun JM; Dhote R; Brézin A
    Ocul Immunol Inflamm; 2005; 13(2-3):225-7. PubMed ID: 16019683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FEATURES OF OPTICAL COHERENCE TOMOGRAPHY FOR THE DIAGNOSIS OF VOGT-KOYANAGI-HARADA DISEASE.
    Liu XY; Peng XY; Wang S; You QS; Li YB; Xiao YY; Jonas JB
    Retina; 2016 Nov; 36(11):2116-2123. PubMed ID: 27145255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BACILLARY LAYER DETACHMENT IN ACUTE VOGT-KOYANAGI-HARADA DISEASE: A Novel Swept-Source Optical Coherence Tomography Analysis.
    Agarwal A; Freund KB; Kumar A; Aggarwal K; Sharma D; Katoch D; Bansal R; Gupta V;
    Retina; 2021 Apr; 41(4):774-783. PubMed ID: 32833410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Optical coherence tomography angiography of acute Vogt-Koyanagi-Harada disease].
    Jia SS; Zhao C; Gong D; Chen Z; Zhang MF
    Zhonghua Yan Ke Za Zhi; 2017 Oct; 53(10):735-739. PubMed ID: 29050185
    [No Abstract]   [Full Text] [Related]  

  • 12. Vogt-Koyanagi-Harada disease following BCG vaccination and tuberculosis.
    Dogan B; Erol MK; Cengiz A
    Springerplus; 2016; 5():603. PubMed ID: 27247899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tomographic features of serous retinal detachment in Vogt-Koyanagi-Harada syndrome.
    Maruyama Y; Kishi S
    Ophthalmic Surg Lasers Imaging; 2004; 35(3):239-42. PubMed ID: 15185793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic Function of 3D Optical Coherence Tomography Images in Diagnosis of Vogt-Koyanagi-Harada Disease at Acute Uveitis Stage.
    Zhao GL; Li RZ; Pang YH; Wang XQ; Peng HJ; Wei JF; Zhou Z
    Med Sci Monit; 2018 Feb; 24():687-697. PubMed ID: 29396390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pathophysiology of macular diseases--morphology and function].
    Iida T
    Nippon Ganka Gakkai Zasshi; 2011 Mar; 115(3):238-74; discussion 275. PubMed ID: 21476310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optical Intensities of Different Compartments of Subretinal Fluid in Acute Vogt-Koyanagi-Harada Disease.
    Lin D; Luo X; Meng L; Zhang G; Chen W; Chen H
    PLoS One; 2016; 11(2):e0149376. PubMed ID: 26871896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in Central Macular Thickness and Retinal Nerve Fiber Layer Thickness in Eyes with Vogt-Koyanagi-Harada Disease: A 2-Year Follow-Up Study.
    Han YS; Shin KS; Lee WH; Kim JY
    Ophthalmologica; 2018; 239(2-3):143-150. PubMed ID: 29339644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resolution of subretinal fluid with systemic corticosteroid treatment in acute Vogt-Koyanagi-Harada disease.
    Nazari H; Rao NA
    Br J Ophthalmol; 2012 Nov; 96(11):1410-4. PubMed ID: 22942161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinal pigment epithelial changes in chronic Vogt-Koyanagi-Harada disease: fundus autofluorescence and spectral domain-optical coherence tomography findings.
    Vasconcelos-Santos DV; Sohn EH; Sadda S; Rao NA
    Retina; 2010 Jan; 30(1):33-41. PubMed ID: 20010321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multispectral image analysis in Vogt-Koyanagi-Harada disease.
    Huang G; Peng J; Ye Z; Kijlstra A; Zhang D; Yang P
    Acta Ophthalmol; 2018 Jun; 96(4):411-419. PubMed ID: 29220112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.